China Records Growth in New Drug Applications for 2021
The beginning of June has seen the release of 2021 Drug Review Annual Report by China’s Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA). In 2021, the drug review work has achieved new records by accomplishing 47 innovative new drug approvals. In addition, the completion rate of on-time review & approval of…